Berenberg lowered the firm’s price target on AstraZeneca to 12,500 GBp from 13,300 GBp and keeps a Buy rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AZN:
- Mixed Day for Vaccine Stocks as Terrible News Emerges
- AstraZeneca sBLA for Flumist Quadrivalent accepted for review by FDA
- AstraZeneca says FDA accepts sBLA for self-administration FluMist Quadrivalent
- AstraZeneca to hold a virtual meeting
- AstraZeneca: Enhertu demonstrated meaningful survival in Phase II trial